Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Board discusses new eyelid and retinal devices; keeps current neutral stance while seeking DA guidance
Summary
Members reviewed several newer noninvasive devices targeting eyelids, meibomian glands and, potentially, retinal tissue (low-level light therapy, IPL, radiofrequency). The board said it has not adopted a new regulatory stance and is awaiting further guidance from the district attorney's office and staff legal review.
Board members discussed an increasing number of noninvasive devices marketed for eyelid tightening, meibomian gland dysfunction and other ocular-surface and periocular conditions. Members said the devices use light, radiofrequency and interchangeable treatment heads and that multiple manufacturers are entering the market.
The board's secretary-treasurer (name not specified) described the devices as "noninvasive procedure[s], not making any incisions on the skin," and noted that "at this point in time, we…
Already have an account? Log in
Subscribe to keep reading
Unlock the rest of this article — and every article on Citizen Portal.
- Unlimited articles
- AI-powered breakdowns of topics, speakers, decisions, and budgets
- Instant alerts when your location has a new meeting
- Follow topics and more locations
- 1,000 AI Insights / month, plus AI Chat
